MedTrace Logo

Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking

NCT05385055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 974

Last updated 2026-05-08

Study results available
· View outcomes & findings →

Summary

This is a cross-sectional 3-group study with subjects enrolled and matched by region (Asia, Europe), age, sex, and average daily product consumption over the last 2 years as self-reported. The study will be conducted as a multi-center and multi-regional study.

Conditions

Interventions

OTHER

THS use

N/A: No intervention was assigned.

OTHER

Cigarette smoking

N/A: No intervention was assigned.

OTHER

Smoking abstinence

N/A: No intervention was assigned.

Sponsors & Collaborators

  • Philip Morris Products S.A.

    lead INDUSTRY

Principal Investigators

  • Christelle Haziza, PhD · Philip Morris Products S.A.

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2023-12-27
Completion
2024-04-23

Countries

  • Bulgaria
  • Czechia
  • Germany
  • Greece
  • Japan
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05385055 on ClinicalTrials.gov